Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

0.7879
Delayed Data
As of 3:59pm ET
 +0.0279 / +3.67%
Today’s Change
0.74
Today|||52-Week Range
2.35
-22.75%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Quarter 3
2015
Revenue and IncomeNet Revenues1.4M5.1M4.6M5.8M
 
 
 
 
 
Cost of Goods Sold855.0K1.8M1.4M1.8M
 
 
 
 
 
Depreciation And Amortization722.0K616.0K607.0K588.0K
 
 
 
 
 
 
Operating ExpensesGross Income-193.0K2.7M2.6M3.5M
 
 
 
 
 
General Expenses8.9M8.7M8.6M7.5M
 
 
 
 
 
Research And Development6.5M6.8M6.5M5.3M
 
 
 
 
 
Total Operating Expenses10.4M11.1M10.6M9.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.0M-6.0M-6.0M-4.0M
 
 
 
 
 
Interest Expense On Debt1.4M1.2M642.0K1.0M
 
 
 
 
 
Other Expenses2.0M1.1M1.5M1.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.5M-6.0M-5.1M-3.8M
 
 
 
 
 
Net Income-8.5M-6.0M-5.1M-3.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS93.6M93.2M93.6M93.9M
 
 
 
 
 
Shares To Calculate EPS Diluted93.6M93.2M93.6M93.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.09-$0.06-$0.05-$0.04
 
 
 
 
 
EPS Diluted-$0.09-$0.06-$0.05-$0.04